Elkimia is proud to announce that it has entered into licensing agreement with Sensient Technologiesto manufacture and commericialize its first Microsporin Amino mimic derived from Elkimia’s innovative platform.
" I am happy to see that all the hard work paid off and we look forward to deepening our partnership with Sensient and explore the commerical potential of our products. "